Literature DB >> 1088999

The kinetics and regulation of granulopoiesis.

W A Robinson, A Mangalik.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1088999

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  7 in total

1.  Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice.

Authors:  A A Mahmoud; M K Stone; R W Kellermeyer
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

Review 2.  Relationship between diseases accompanied by tissue destruction and granulocytes with surface adrenergic receptors.

Authors:  Toru Abo; Toshihiko Kawamura; Hiroki Kawamura; Chikako Tomiyama-Miyaji; Yasuhiro Kanda
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.

Authors:  Manfred Weiss; Sami Voglic; Britt Harms-Schirra; Ingrid Lorenz; Britta Lasch; Kristoffel Dumon; Wilhelm Gross-Weege; Elisabeth Marion Schneider
Journal:  Intensive Care Med       Date:  2003-04-08       Impact factor: 17.440

4.  Granulopoietic studies in acute lymphocytic leukemia of children.

Authors:  A Mangalik; W A Robinson; C P Holton
Journal:  Blut       Date:  1977-02

Review 5.  Leitartikel.

Authors:  W A Robinson; O G Stonington
Journal:  Blut       Date:  1976-01

6.  Haematological findings in type Ib glycogen storage disease before and after portacaval shunt.

Authors:  L Corbeel; M Boogaerts; G Van den Berghe; M C Everaerts; G Marchal; R Eeckels
Journal:  Eur J Pediatr       Date:  1983 Jun-Jul       Impact factor: 3.183

Review 7.  Stem cell assays in the evaluation of myelotoxicity.

Authors:  A Mangalik; W A Robinson
Journal:  Environ Health Perspect       Date:  1981-06       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.